Replimune Group Executives Sell Shares to Cover Tax Obligations
閱讀少於1分鐘
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Sarchi Christopher | Chief Commercial Officer | Sell | $56,131 | Form 4 |
| Xynos Konstantinos | Chief Medical Officer | Sell | $78,111 | Form 4 |
Christopher Sarchi, Chief Commercial Officer of Replimune Group, sold 5,207 shares of common stock on November 18, 2024, at a price of $10.78 per share, totaling $56,131, to cover tax withholding obligations related to the partial vesting of Restricted Stock Units. Following this transaction, Sarchi directly owns 87,045 shares of Replimune Group's common stock.
Konstantinos Xynos, the Chief Medical Officer of Replimune Group, sold 7,246 shares of common stock on November 18, 2024, at a price of $10.78 per share, totaling $78,111, to cover tax withholding obligations related to the partial vesting of Restricted Stock Units. Following this transaction, Xynos directly owns 109,885 shares of Replimune Group's common stock.